Comparative Effects of Propioceptive Neuromascular Facilitation and Neural Flossing in Diabetic Neuropathy
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 29, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two different treatments—proprioceptive neuromuscular facilitation (a type of physical therapy that helps improve movement and balance) and neural flossing (a technique aimed at relieving nerve tension)—to see which one better helps people with diabetic peripheral neuropathy. Diabetic peripheral neuropathy is a condition that can cause pain, numbness, and problems with balance and walking due to nerve damage from diabetes. The trial is currently recruiting participants aged 45 to 65 who have been diagnosed with type I or II diabetes and have mild symptoms as measured by a specific screening tool.
To be eligible for this study, participants should be able to stand and walk on their own without help and should not have other serious health issues that could affect their participation, like major nerve or joint problems. If you or someone you know fits this description and is interested in helping researchers find better treatments for balance and walking problems caused by diabetes, this trial may be a good opportunity. Participants can expect to engage in physical therapy sessions focused on the two techniques being compared and contribute to important research that could improve the quality of life for many individuals with diabetic neuropathy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinically Diagnosed with type I and II diabetes
- • Patients 45 to 65 years of age
- • The participants who scored \<3 as per the Michigan Neuropathy Screening Instrument (MNSI) were included in the study.
- • Able to stand and walk without assistance
- Exclusion Criteria:
- • Patients have other neurological or orthopedic impairments (such as stroke,cerebral palsy, poliomyelitis, rheumatoid arthritis, prosthesis, or moderate or severe osteoarthritis)
- • Major vascular complications (venous or arterial ulcers).
- • Severe retinopathy
- • Severe nephropathy that causes edema or requires haemodialysis
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burewala, Punjab, Pakistan
Patients applied
Trial Officials
Sana Akram, DPT
Principal Investigator
Riphah International University (Lahore)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported